Triptorelin
Decapeptyl, Trelstar, Gonapeptyl, Pamorelin
A synthetic GnRH agonist decapeptide that suppresses gonadotropin and sex hormone production for treating prostate cancer, endometriosis, and precocious puberty.
Completed
NCT01206803
Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients
University Hospital Schleswig-Holstein
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT00751790
Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer
Debiopharm International SA
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT02825290
Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study
Sheba Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NCT03105323
Role of Ratio of Progesterone to Number of Follicles as a Prognostic Tool for IntracytoplasmicSperm Injection Outcome
Ain Shams Maternity Hospital
OBSERVATIONAL
Updated Dec 15, 2025
Completed
PHASE2, PHASE3
NCT01160315
Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure
Erasme University Hospital
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT02477566
Comparative Study of Long-acting and Short Acting Triptorelin in PCOS Patients Who Underwent IVF/ICSI
Nanjing University
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT01764230
Prevention of Ovarian Function Damage by a GnRH Analogue During Chemotherapy in Hodgkin Lymphoma Patients
Masaryk University
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT05781217
Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT01638026
Final Oocyte Maturation Via Administration of GnRH Agonists Followed By Luteal Support With hCG
HaEmek Medical Center, Israel
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT05879926
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NRG Oncology
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT06191809
Evaluate the Effectiveness of Progestin-Primed Versus GnRH Antagonist Protocols in Vietnamese Women Undergoing In-vitro Fertilization
Hanoi Medical University
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE2
NCT04869371
Androgen Deprivation Therapy Combined With Docetaxel for High Risk Prostate Cancer
Hongqian Guo
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT00104741
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
UNICANCER
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
NA
NCT02346253
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
Stanford University
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT00375687
Investigation of Early Hormonotherapy Efficacy of Prostate Cancer
Kaunas University of Medicine
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
NA
NCT03142035
Dienogest Versus GnRH-a Pre-treatment in Women With Endometriosis Undergoing IVF
American University of Beirut Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
PHASE3
NCT00567580
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
Radiation Therapy Oncology Group
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT04659551
Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients
Istituto Oncologico Veneto IRCCS
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE2
NCT05555017
Tracer-Guided Surgery for Recurrent Prostate Cancer
The Netherlands Cancer Institute
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE3
NCT06513962
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
Children's Oncology Group
INTERVENTIONAL
Updated Dec 15, 2025